Insiders who reported open-market trades in the last 12 months at the companies John P. Butler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Nicholas Grund - $118K in AKBA purchases and sales in the last 12 months
Erik Ostrowski - $111K in AKBA purchases and sales in the last 12 months
Carolyn M. Rucci - $97K in AKBA purchases and sales in the last 12 months
Steven Keith Burke - $94K in AKBA purchases and sales in the last 12 months
Richard C. Malabre - $69K in AKBA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
John P. Butler is a corporate insider, tracked as CEO and President, Director of Akebia Therapeutics, Inc. (AKBA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John P. Butler submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John P. Butler been buying or selling stock?
Recorded transactions: 1 open-market purchase ($87K) and 4 open-market sales ($474K) across all tracked filings.
John P. Butler is CEO and President, Director of Akebia Therapeutics, Inc. (AKBA). 4 SEC Form 4 filings on record, most recently on 10 August 2026. Most recent open-market trade: bought $87K of AKBA on 5 March 2026. Lifetime open-market purchases: $87K. Lifetime open-market sales: $474K.
Recent transactions
8
The latest 8 SEC Form 4 transactions reported by John P. Butler.
InsiderAlpha's records for John P. Butler go back to 2026: 4 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $87K (1 buy totaling $87K). The largest single buy on record is $87K of AKBA in 2026. Sales side: 4 recorded sales totaling $474K, so the filing history runs sell-heavy by dollar value. 5 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
